Vitalhub (TSE:VHI) Announces Quarterly Earnings Results

Vitalhub (TSE:VHI) issued its quarterly earnings results on Thursday. The company reported C$0.04 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of C$31.91 million during the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.

Vitalhub Stock Up 1.1%

Shares of VHI stock opened at C$7.94 on Friday. The company’s fifty day simple moving average is C$7.69 and its two-hundred day simple moving average is C$8.63. Vitalhub has a 52 week low of C$6.67 and a 52 week high of C$14.64. The stock has a market cap of C$502.06 million, a P/E ratio of 79.40, a PEG ratio of 1.18 and a beta of 0.87.

Insider Transactions at Vitalhub

In other news, Director Francis Nelson Shen purchased 439,600 shares of the company’s stock in a transaction that occurred on Tuesday, March 24th. The stock was bought at an average cost of C$7.00 per share, with a total value of C$3,077,200.00. Following the completion of the purchase, the director owned 588,300 shares in the company, valued at approximately C$4,118,100. This represents a 295.63% increase in their ownership of the stock. Also, Director Anthony Pius Shen purchased 7,000 shares of the company’s stock in a transaction that occurred on Monday, March 30th. The shares were purchased at an average cost of C$7.11 per share, with a total value of C$49,770.00. Following the completion of the purchase, the director owned 12,470 shares of the company’s stock, valued at C$88,661.70. The trade was a 127.97% increase in their position. In the last 90 days, insiders have bought 496,600 shares of company stock valued at $3,476,470. Company insiders own 18.57% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on VHI shares. Raymond James Financial dropped their price objective on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research note on Tuesday, March 24th. ATB Cormark Capital Markets decreased their target price on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. Royal Bank Of Canada lowered their price target on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a report on Monday, January 26th. Finally, Scotiabank dropped their price target on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.